Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2696

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 71335-2696). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Structural Formula (Image 1)
Chemical structure diagram of Cyclobenzaprine Hydrochloride showing its molecular arrangement with labeled chemical groups and atoms.*
FDA Label Image

Image (Image 2)

Image (Image 2)
Illustration of a spoon holding a scoop of what appears to be a semi-solid or creamy substance, depicted in black and white line art. The image likely serves as a visual aid or instructional figure related to product usage or administration.*
FDA Label Image

Image (Image 3)

Image (Image 3)
An instructional illustration showing a hand holding a capsule with a marked section labeled 'TOP,' demonstrating how to properly handle or open the capsule. The image is likely related to Cyclobenzaprine Hydrochloride extended release capsules.*
FDA Label Image

Image (Image 4)

Image (Image 4)
An instructional illustration showing how to twist a child-resistant cap labeled "TOP" on a capsule or bottle. One hand holds the cap while the other hand rotates it with arrows indicating the twisting motion.*
FDA Label Image

Image (Image 5)

Image (Image 5)
An instructional illustration showing a hand opening a capsule and emptying small beads or pellets onto a spoon, likely demonstrating how to administer the content of an extended release capsule.*
FDA Label Image

Image (Image 6)

Image (Image 6)
Illustration showing a woman holding a spoon near her mouth as if about to take oral medication, likely indicating the proper way to take the drug orally.*
FDA Label Image

Image (Image 7)

Image (Image 7)
An illustration shows a person drinking a glass of water, demonstrating the proper way to take an oral medication such as a capsule, indicating swallowing the drug with water.*
FDA Label Image

Label (Lbl713352696)

Label (Lbl713352696)
Label for Cyclobenzaprine Hydrochloride Extended-Release Capsules, 30 mg, showing a package of 30 capsules. The label includes the NDC 71335-2696-1, manufacturer Teva Pharmaceuticals USA, Inc., and repackager Bryant Ranch Prepack, Inc. Dosage instructions and storage conditions are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.